Clinical Bioreagent Center

First phase in HIV vaccine project is completed

Submitted on 17 April 2016 - 4:50pm

This article is reproduced by CienciaPR with permission from the original source.

Original Source: 

El Nuevo Día

CienciaPR Contribution: 

No

By: 

Keila López Alicea

The University of Puerto Rico (UPR) is actively engaged in the race to develop a vaccine against HIV. In just 18 month, researchers from the Molecular Sciences Research Center at UPR have succesfully completed the first phase of a project to develop an HIV vaccine and are waiting for NIH aproval to begin the second phase. 

For the full article, please refer to the spanish version of this site. 

 

Tags: 

Subscribe to RSS - Clinical Bioreagent Center